PTA球囊導管市場規模、佔有率和趨勢分析報告：按材料類型、應用、最終用途、地區和細分市場預測，2024-2030年

PTA Balloon Catheter Market Size, Share & Trends Analysis Report By Material Type (Polyurethane, Nylon), By Application (Peripheral Artery Disease), By End-use, By Region, And Segment Forecasts, 2024 - 2030

出版日期: 2024年07月05日 | 出版商:

Grand View Research | 英文 85 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

PTA球囊導管市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年全球PTA球囊導管市場規模將達46.3億美元，2024-2030年複合年成長率為8.32%。

新興國家周邊動脈阻塞性疾病病率的增加和經皮冠狀動脈介入治療（PCI）手術數量的增加是推動市場的關鍵因素。

隨著大多數人採取久坐的生活方式，全球各種類型的心血管疾病的盛行率正在增加。隨著全球心血管疾病患者數量的增加，治療此類疾病的各種手術，例如心導管插入術、血管成形術和經皮冠狀動脈介入治療（PCI），預計將變得更加普遍，球囊導管已成為基本需求之一。

COVID-19 大流行導致患者數量下降，減少了對外科手術的需求，影響了產業成長。根據愛思唯爾的數據，2020年冠狀動脈成形術數量為11.2%，低於先前報告的資料。根據美國國家醫學圖書館的數據，2020 年美國成人心血管手術將減少 52.7%。後期，隨著多個國家取消限制，心臟和周邊手術數量增加。預計這將增加對 PTA 球囊導管等血管成形手術器械的需求。

PTA 球囊導管市場報告亮點

2023年北美市場佔比47.95%。這是由於該地區的產品可用性高、對外科手術的需求高以及認可度高。
由於政府措施和目標疾病數量的增加，預計亞太地區在預測期內將呈現最快的成長速度。
在拉丁美洲，支持醫療設備商業化的政府法規預計將推動產業成長。例如，在拉丁美洲的大多數國家，上市核准申請只需美國FDA或CE標誌核准。
引進最新的醫療技術、聯盟與合作、產品擴展以及併購是主要企業為獲得市場優勢而採取的一些策略。例如，2022 年 2 月，波士頓科學公司收購了 Baylis Medical Company, Inc.，這是一家醫療設備公司，主要提供支援基於導管的左心手術的解決方案。
心臟外科醫師的短缺是世界範圍內的一個主要問題。低收入國家更嚴重地面臨這個問題。例如，在北非，每 110 萬人中只有一名外科醫生。因此，可以進行的手術數量有限，阻礙了該行業的成長。

The global PTA balloon catheter market size is expected to reach USD 4.63 billion by 2030, registering a CAGR of 8.32% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing incidence of peripheral artery disorder and the rising number of Percutaneous Coronary Intervention (PCI) procedures in developing countries are key factors driving the market.

The adoption of a sedentary lifestyle by most of the population has increased the prevalence rate of various types of cardiovascular diseases worldwide. An increase in the number of cases of cardiovascular diseases across the globe is expected to boost the adoption of various procedures-such as cardiac catheterizations, angioplasty, and Percutaneous Coronary Intervention (PCI)-to treat such conditions, wherein PTA balloon catheters are among the essential requirements.

The COVID-19 pandemic resulted in a decline in the number of patient encounters, leading to a reduction in the demand for surgical procedures, thereby impacting the industry growth. According to Elsevier, the number of coronary angioplasty surgeries was 11.2% in 2020, which is lower than the previously reported data. According to the National Library of Medicine, the U.S. witnessed a 52.7% decline in adult cardiac surgeries in 2020. In the later phase, as the restrictions were lifted in several countries, the volume of cardiac and peripheral surgical procedures increased. This is expected to increase the demand for angioplasty surgical devices such as PTA balloon catheters.

PTA Balloon Catheter Market Report Highlights:

North America market dominated with a share of 47.95% in 2023. This can be attributed to the higher product availability, high demand for surgical procedures, and better awareness in the region
Asia Pacific is expected to exhibit the fastest growth rate during the forecast period due to government initiatives and increasing incidence of target disorders
Supportive government regulations to commercialize medical devices in Latin America are expected to impel industry growth. For instance, most Latin American countries only require the U.S. FDA or CE mark approval for filing marketing approvals
Incorporation of the latest health technologies, partnerships and collaborations, product expansion, and mergers & acquisitions are some of the strategies being adopted by key players to gain a competitive edge in the market. For instance, in February 2022, Boston Scientific Corporation acquired Baylis Medical Company, Inc., a medical device company primarily providing solutions to support catheter-based left heart procedures
The shortage of cardiac surgeons worldwide is a big concern. Low-income countries are facing this issue more severely. For instance, North Africa has only one surgeon per 1.1 million people. This is resulting in restricting the number of surgeries that could be performed, hindering industry growth

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Material Type
- 1.2.2. Application
- 1.2.3. End Use
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecast timeline.
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity price analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Material Type Segment
- 2.2.2. Application Segment
- 2.2.3. End Use Segment.
- 2.2.4. Regional Outlook
2.3. Competitive Insights

Chapter 3. Global PTA Balloon Catheter Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Increasing Prevalence of Cardiovascular Diseases
  - 3.2.1.2. Growing Adoption of Minimally Invasive Procedures
- 3.2.2. Market restraint analysis
  - 3.2.2.1. Potential Complications Associated with Angioplasty Procedures
  - 3.2.2.2. Stringent Regulatory Policies
3.3. PTA Balloon Catheter Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Technological landscape
  - 3.3.2.3. Economic landscape

Chapter 4. PTA Balloon Catheter Market: Material Type Estimates & Trend Analysis

4.1. PTA Balloon Catheter Market: Material Type Dashboard
4.2. PTA Balloon Catheter Market: Material Type Movement Analysis
4.3. PTA Balloon Catheter Market Size & Forecasts and Trend Analysis, by Material Type, 2018 to 2030 (USD Million)
4.4. Nylon
- 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. Polyurethane
- 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.6. Others
- 4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. PTA Balloon Catheter Market: Application Estimates & Trend Analysis

5.1. PTA Balloon Catheter Market: Application Dashboard
5.2. PTA Balloon Catheter Market: Application Movement Analysis
5.3. PTA Balloon Catheter Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Peripheral Artery Disease
- 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5. Coronary Artery Disease
- 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. PTA Balloon Catheter Market: End Use Estimates & Trend Analysis

6.1. PTA Balloon Catheter Market: End Use Dashboard
6.2. PTA Balloon Catheter Market: End Use Movement Analysis
6.3. PTA Balloon Catheter Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Hospitals
- 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.5. Ambulatory Surgical Centers
- 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.6. Others
- 6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. PTA Balloon Catheter Market: Regional Estimates & Trend Analysis by Country, Material Type, Application, & End Use

7.1. Global PTA Balloon Catheter Market: Regional Dashboard
7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
7.3. North America
- 7.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.3.2. U.S.
  - 7.3.2.1. Key country dynamics
  - 7.3.2.2. Regulatory framework/ reimbursement structure
  - 7.3.2.3. Competitive scenario
  - 7.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.3. Canada
  - 7.3.3.1. Key country dynamics
  - 7.3.3.2. Regulatory framework/ reimbursement structure
  - 7.3.3.3. Competitive scenario
  - 7.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.4. Mexico
  - 7.3.4.1. Key country dynamics
  - 7.3.4.2. Regulatory framework/ reimbursement structure
  - 7.3.4.3. Competitive scenario
  - 7.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
7.4. Europe
- 7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.4.2. UK
  - 7.4.2.1. Key country dynamics
  - 7.4.2.2. Regulatory framework/ reimbursement structure
  - 7.4.2.3. Competitive scenario
  - 7.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.3. Germany
  - 7.4.3.1. Key country dynamics
  - 7.4.3.2. Regulatory framework/ reimbursement structure
  - 7.4.3.3. Competitive scenario
  - 7.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.4. France
  - 7.4.4.1. Key country dynamics
  - 7.4.4.2. Regulatory framework/ reimbursement structure
  - 7.4.4.3. Competitive scenario
  - 7.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.5. Italy
  - 7.4.5.1. Key country dynamics
  - 7.4.5.2. Regulatory framework/ reimbursement structure
  - 7.4.5.3. Competitive scenario
  - 7.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.6. Spain
  - 7.4.6.1. Key country dynamics
  - 7.4.6.2. Regulatory framework/ reimbursement structure
  - 7.4.6.3. Competitive scenario
  - 7.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.7. Sweden
  - 7.4.7.1. Key country dynamics
  - 7.4.7.2. Regulatory framework/ reimbursement structure
  - 7.4.7.3. Competitive scenario
  - 7.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.8. Norway
  - 7.4.8.1. Key country dynamics
  - 7.4.8.2. Regulatory framework/ reimbursement structure
  - 7.4.8.3. Competitive scenario
  - 7.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.9. Denmark
  - 7.4.9.1. Key country dynamics
  - 7.4.9.2. Regulatory framework/ reimbursement structure
  - 7.4.9.3. Competitive scenario
  - 7.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
7.5. Asia Pacific
- 7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.5.2. China
  - 7.5.2.1. Key country dynamics
  - 7.5.2.2. Regulatory framework/ reimbursement structure
  - 7.5.2.3. Competitive scenario
  - 7.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
- 7.5.3. Japan
  - 7.5.3.1. Key country dynamics
  - 7.5.3.2. Regulatory framework/ reimbursement structure
  - 7.5.3.3. Competitive scenario
  - 7.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
- 7.5.4. India
  - 7.5.4.1. Key country dynamics
  - 7.5.4.2. Regulatory framework/ reimbursement structure
  - 7.5.4.3. Competitive scenario
  - 7.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
- 7.5.5. Australia
  - 7.5.5.1. Key country dynamics
  - 7.5.5.2. Regulatory framework/ reimbursement structure
  - 7.5.5.3. Competitive scenario
  - 7.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
- 7.5.6. Thailand
  - 7.5.6.1. Key country dynamics
  - 7.5.6.2. Regulatory framework/ reimbursement structure
  - 7.5.6.3. Competitive scenario
  - 7.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
- 7.5.7. South Korea
  - 7.5.7.1. Key country dynamics
  - 7.5.7.2. Regulatory framework/ reimbursement structure
  - 7.5.7.3. Competitive scenario
  - 7.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
7.6. Latin America
- 7.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.6.2. Brazil
  - 7.6.2.1. Key country dynamics
  - 7.6.2.2. Regulatory framework/ reimbursement structure
  - 7.6.2.3. Competitive scenario
  - 7.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.3. Argentina
  - 7.6.3.1. Key country dynamics
  - 7.6.3.2. Regulatory framework/ reimbursement structure
  - 7.6.3.3. Competitive scenario
  - 7.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
7.7. MEA
- 7.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.7.2. Saudi Arabia
  - 7.7.2.1. Key country dynamics
  - 7.7.2.2. Regulatory framework/ reimbursement structure
  - 7.7.2.3. Competitive scenario
  - 7.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.3. South Africa
  - 7.7.3.1. Key country dynamics
  - 7.7.3.2. Regulatory framework/ reimbursement structure
  - 7.7.3.3. Competitive scenario
  - 7.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.4. UAE
  - 7.7.4.1. Key country dynamics
  - 7.7.4.2. Regulatory framework/ reimbursement structure
  - 7.7.4.3. Competitive scenario
  - 7.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.5. Kuwait
  - 7.7.5.1. Key country dynamics
  - 7.7.5.2. Regulatory framework/ reimbursement structure
  - 7.7.5.3. Competitive scenario
  - 7.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis, By Key Manufacturers
8.2. Company/Competition Categorization
8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Key company market share analysis, 2023
- 8.3.4. Medtronic
  - 8.3.4.1. Company overview
  - 8.3.4.2. Financial performance
  - 8.3.4.3. Application benchmarking
  - 8.3.4.4. Strategic initiatives
- 8.3.5. Tuermo Corporation
  - 8.3.5.1. Company overview
  - 8.3.5.2. Financial performance
  - 8.3.5.3. Application benchmarking
  - 8.3.5.4. Strategic initiatives
- 8.3.6. Cardinal Health
  - 8.3.6.1. Company overview
  - 8.3.6.2. Financial performance
  - 8.3.6.3. Application benchmarking
  - 8.3.6.4. Strategic initiatives
- 8.3.7. Boston Scientific Corporation.
  - 8.3.7.1. Company overview
  - 8.3.7.2. Financial performance
  - 8.3.7.3. Application benchmarking
  - 8.3.7.4. Strategic initiatives
- 8.3.8. Natec Medical
  - 8.3.8.1. Company overview
  - 8.3.8.2. Financial performance
  - 8.3.8.3. Application benchmarking
  - 8.3.8.4. Strategic initiatives
- 8.3.9. Cook Medical
  - 8.3.9.1. Company overview
  - 8.3.9.2. Financial performance
  - 8.3.9.3. Application benchmarking
  - 8.3.9.4. Strategic initiatives
- 8.3.10. Biotronik
  - 8.3.10.1. Company overview
  - 8.3.10.2. Financial performance
  - 8.3.10.3. Application benchmarking
  - 8.3.10.4. Strategic initiatives
- 8.3.11. Surmodics, Inc.
  - 8.3.11.1. Company overview
  - 8.3.11.2. Financial performance
  - 8.3.11.3. Application benchmarking
  - 8.3.11.4. Strategic initiatives
- 8.3.12. Andratec
  - 8.3.12.1. Company overview
  - 8.3.12.2. Financial performance
  - 8.3.12.3. Application benchmarking
  - 8.3.12.4. Strategic initiatives